May 2, 2023
DNAstack launches Neuroscience AI to accelerate collaborative research and discovery
Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before.Read More
For media requests, please contact press@dnastack.com.
Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before.Read More
The new project will help expand federated, AI-powered insights across distributed networks of genomics and health data. Read More
Award recognizes Toronto company’s global impact on genomics and health research.
David Miller, PacBio VP of product marketing, highlighted the company’s partnerships, including with Hamilton, Miroculus, the Broad Institute, Twist Biosciences, Google Health, DNAnexus, and DNAstack, for various companion offerings to enhance its sequencing workflow.
Publication in Cell on the genomic architecture of autism from comprehensive genomic analysis of over 11,000 individuals.
DNAstack CEO Marc Fiume presents a vision for an Internet for Pandemic Surveillance at the 10th Plenary Meeting of the Global Alliance for Genomics & Health (GA4GH) in Barcelona, Spain.
DNAstack CEO Dr. Marc Fiume spoke with Angie Seth of CTV on his vision for an Internet for Pandemic Surveillance.
DNAstack drives medical breakthroughs with its federated data discovery and analysis platform built on open standards. The company was selected for establishing federated data networks and powering insights in pandemic surveillance, neuroscience, rare disease, and oncology.
Harnessing artificial intelligence to take the guesswork out of diagnosing cancer recurrence for millions of cancer survivors
DNAstack today announced Viral AI, a federated network for genomic variant surveillance and infectious disease research. Viral AI was designed to deliver equitable access to software infrastructure, accelerate international data sharing, and empower scientists and public health officials with globally representative datasets they need to mitigate current and future infectious disease outbreaks.
Our world is constantly changing and at its core, innovation is really about responding to change in a new, creative way. It requires courage, conviction, resilience, the support of a community of collaborators, and innovation-oriented policies in order to succeed.Read More
A coalition of researchers and healthcare providers in Canada and beyond are building what they believe to be the first global, federated network for sharing genomics and clinical data to support advances in research and patient care for autism (Subscriber content).
Canada’s Digital Technology Supercluster and DNAstack today announced the Autism Sharing Initiative, a new project to build the first federated, global network for sharing genomics and clinical data to accelerate research with the hopes of developing precision healthcare approaches for autistic individuals.
Genome Canada launched the Canadian VirusSeq Data Portal today to track the evolving COVID-19 pandemic across Canada.
Genome Canada, in partnership with the Government of Canada, is pleased to announce the development of a new Canadian SARS-CoV-2 Data Portal.
The Ontario government has unveiled a six-point plan to prevent and stop the spread of new COVID-19 variants.
A consortium of Canadian informatics firms, pharmaceutical companies, and research institutes has pledged C$5.1 million to tailor a bioinformatics and health data platform for COVID-19 research across the country.
The Digital Technology Supercluster has made $10.7 million in follow-on investments to five projects under its COVID-19 stream, rounding out the Supercluster’s $60 million budget for the pandemic-focused program.
Today, DNAstack revealed a software system built on standards developed by the Global Alliance for Genomics and Health (GA4GH) to enable federated analysis of genomics and related health data.
To combat the current COVID-19 pandemic, scientists around the world are sequencing viral genomes at an accelerated pace.
DNAstack today announced COVID Cloud, an online destination for exploring one of the largest collections of viral genome sequences in the world.
DNAstack’s bioinformatician Heather Ward breaks down the biology of the novel coronavirus responsible for the COVID-19 outbreak.
Canada’s Digital Technology Supercluster is supporting Canadians in the fight against COVID-19.
DNAstack today introduced a Beacon for SARS-CoV-2, commonly known as COVID-19, available at covid-19.dnastack.com.
Toronto company is ‘getting noticed’ as it works to build the digital infrastructure to power the next generation of scientific research.
Despite advances in sequencing and analysis tools, calling variants in whole-genome sequencing (WGS) data is not trivial, even when dealing with only a few dozen samples.
DNAstack today announced the launch of Clinical Evidence Beacons on the Beacon Network, a real-time search engine for finding genetic mutations across a global network of genomic datasets.Read More
Project partners will expand on infrastructure developed by DNAstack for accessing genomic data and explore patient consent models that support nationwide sharing.
Here we describe the Beacon protocol and how it can be used as a model for the federated discovery and sharing of genomic data.
The Government of Canada is investing up to $950 million over five years to support industry-led innovation superclusters across the country and accelerate economic growth, productivity, and competitiveness across five Superclusters.
Newly released APIs are the first products from the Global Alliance for Genomics and Health‘s strategic roadmap for interoperability of genomic data.
ClinGen has joined with the Global Alliance for Genomics and Health (GA4GH) to support the development of open, freely‐available technical standards and regulatory frameworks for secure and responsible sharing of genomic and health‐related data.
The Global Alliance for Genomics and Health (GA4GH) proposes a data access policy model—“registered access”—to increase and improve access to data requiring an agreement to basic terms and conditions, such as the use of DNA sequence and health data in research.
The Autism Speaks MSSNG project will help researchers answer the many remaining questions about the genetic underpinnings of autism by sequencing the DNA of over 10,000 families affected by autism.
The volume of genomics and health data is growing rapidly, driven by sequencing for both research and clinical use.
The Global Alliance for Genomics and Health (GA4GH) has announced their Strategic Roadmap, which includes a series of more than two dozen deliverables to be launched in 2018 and developed over the next one to three years.
DNAstack, Canada’s Genomics Enterprise, Google, the Centre of Genomics and Policy, and more announce the launch of the Canadian Genomics Cloud (CGC): a national cloud-based infrastructure for genomics initiatives to share data across Canada.
Not only was Michael Szego the ethics lead on the Personal Genome Project Canada — he was also a participant, agreeing to have his genome mapped and shared publicly.
The Personal Genome Project Canada is a comprehensive public data resource that integrates whole genome sequencing data and health information.
We fundamentally believe that democratization of genomics information through sharing will massively accelerate discoveries that will lead to better treatments and outcomes for patients affected by genetic diseases.
The purpose of this study was to develop a national program for Canadian diagnostic laboratories to compare DNA-variant interpretations and resolve discordant-variant classifications using the BRCA1 and BRCA2 genes as a case study.
Almost sixty percent of the human population resides in Asia and Africa, but only a fraction of the world’s human genomic sequencing efforts cover that community.
The Beacon Project of the Global Alliance for Genomics and Health (GA4GH) and ELIXIR, the European infrastructure for life-science data, announced today an expansion of their partnership to develop the Beacon Project that will improve the discoverability of European genomic data.
Members of the International Canadian Data Sharing Initiative (Can-SHARE) have announced the recipients of C$700,000 ($522,000) in funding under their New Initiatives program.
This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine.
In today’s Science, the Global Alliance for Genomics and Health (GA4GH) calls for a federated data ecosystem for sharing genomic and clinical data.
Early data-sharing efforts have led to improved variant interpretation and development of treatments for rare diseases and some cancer types.
JLABS will let startups in therapeutic, pharmaceutical, medical device and consumer health research test out ideas with access to state-of-the-art equipment, without giving up equity.
Genome Canada and the Canadian Institutes of Health Research (CIHR) today announced a $3.3 million investment in Can-SHARE – a pan-Canadian program that will enable innovation in the use of genomic data for health care for patients in Canada and worldwide.
The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.
Through its Data Working Group, GA4GH wants to replace many existing standards, conventions, and file formats with new ones that will scale to searching through genomes at the level of whole populations ― and, crucially, make it easier for separate organizations to share data.
The DNAstack platform is built on Google Genomics and Google Cloud Platform, giving researchers fast, easy, and more secure access to genomics data for analysis and sharing.
In February MIT Technology Review chose their 10 Breakthrough Technologies of 2015—here’s how they have advanced since.
A coalition of geneticists and computer programmers calling itself the Global Alliance for Genomics and Health is developing protocols for exchanging DNA information across the Internet.
Research labs across Ontario are full of ingenious – and even life-saving – inventions.